Mereo BioPharma Group plc (MREO) stock
MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.29+0.01 (+5.39%)
Close on Nov 18, 2026Market cap $46.20MP/E –Yield –
Mereo BioPharma profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Mereo BioPharma's profit margin for the twelve months ending Dec 31, 2025 was -8375.6%. For fiscal 2025 it was -8375.6%, against -294.7% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -8375.6% | −8080.9 |
| FY2023 | Dec 31, 2023 | -294.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -732.9% | – |
| Q2 FY2025 | Jun 30, 2025 | -2923.2% | – |
| Q4 FY2023 | Dec 31, 2023 | -910.9% | – |
| Q2 FY2023 | Jun 30, 2023 | -19.5% | – |
See a number that looks wrong?